Agarwal Arjun sold ORKA
May 18, 2026 · Form 4 insider transaction
Agarwal Arjun sold 800 shares of Oruka Therapeutics, Inc. at $60.34 per share, a transaction worth $48.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
800
Price
$60.34
Total value
$48.3K
InsiderAgarwal Arjun
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 18, 2026
Filing dateMay 18, 2026
Shares owned after17,106
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.78 to $60.72, inclusive.